{
    "code": "01032641",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=01032641",
    "time": "2020-02-25 05:40:29",
    "許可證字號": "衛署藥製字第032641號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "109\/05\/29",
    "發證日期": "79\/05\/29",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHY00103264103",
    "中文品名": "固爾痛錠２５０公絲（待福索）",
    "英文品名": "GUERTON TABLETS 250MG (DIFLUNISAL)",
    "適應症": "骨關節炎（退化性關節疾病），外傷或扭傷引起之疼痛，生產女陰切開後之疼痛，骨科及牙科手術之疼痛",
    "劑型": "110錠劑",
    "包裝": "盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": [
        ""
    ],
    "藥品類別": "06須由醫師處方使用",
    "藥品分類": "",
    "主製造廠": {
        "限制項目": "01國　產",
        "申請商名稱": "0402211200  中美兄弟製藥股份有限公司",
        "申請商地址": "彰化市東芳里彰鹿路１０６號",
        "主製造廠": ""
    },
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "2808600700",
            "成分名稱": "DIFLUNISAL",
            "含量描述": "250",
            "含量": "250.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "0148-固爾痛錠-說-104-12-17(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01032641&Seq=001&Type=9"
        },
        {
            "title": "0148-固爾痛錠-盒-104-12-17(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01032641&Seq=001&Type=8"
        }
    ]
}